Left Breast Regional Nodal Irradiation With Cardiac Sparing Trade-Offs
A 47-year-old woman with left breast invasive ductal carcinoma, pT1cN1 (two sentinel nodes positive), status post breast-conserving surgery with oncoplastic closure, is planned for whole breast 50 Gy in 25 fractions, sequential tumor bed boost 10 Gy in 5 fractions, and regional nodal irradiation to the supraclavicular and internal mammary nodes. Two VMAT plans are generated. Plan A: heart mean 6.8 Gy, LAD max 44 Gy, left lung V20 18%, PTV V95 98%. Plan B (prone): heart mean 2.4 Gy, LAD max 26 Gy, left lung V20 29%, PTV V95 93%, with a cold spot in the supraclavicular region. Her hypertension is controlled, and the supraclavicular PTV is 14 cm3. She has palpitations and a family history of coronary disease. She cannot tolerate deep inspiration breath hold.
1. Which plan would you recommend, and what factors beyond mean heart dose drive the decision?
Read the worked answer
Recommendation: start with Plan B only if the supraclavicular cold spot can be corrected; otherwise use an optimized Plan A or a hybrid. Plan A has acceptable target coverage and lung dose, but heart mean 6.8 Gy and LAD max 44 Gy are unfavorable for a 47-year-old with palpitations and family history. Plan B lowers heart mean to 2.4 Gy and LAD to 26 Gy, which is clinically meaningful for late cardiac risk, but PTV V95 of 93% and a supraclavicular cold spot are not acceptable for regional nodal irradiation because underdosing improves the chance of nodal recurrence. Left lung V20 of 29% is also higher and could increase pneumonitis risk, although the absolute risk is lower than the cardiac risk. The decision is not mean heart dose alone: cardiac substructure dose, target coverage, lung dose, and reproducibility matter. I would re-optimize prone or supine VMAT with cardiac avoidance, and if a plan can achieve PTV V95 ≥95% with heart mean <4 Gy and LAD max <30 Gy, use it. If not, consider proton therapy.
2. What additional planning or delivery strategies could reduce cardiac and pulmonary dose without compromising target coverage?
Read the worked answer
Strategies include prone positioning with careful breast support; respiratory gating in free breathing; VMAT with avoidance sectors and cardiac substructure objectives; treating only the breast in the prone position and using a separate matched electron or photon field for supraclavicular nodes; and a tumor bed boost with electrons or brachytherapy to avoid extra heart dose. Internal mammary irradiation should use a technique that limits heart and LAD; if internal mammary coverage cannot be achieved without high cardiac dose, discuss the marginal benefit with the patient. Use daily image guidance and verify the cold spot. Document that cardiac sparing is a priority but not at the cost of gross target undercoverage.